Characterizing the Mechanism of Doxorubicin Mediated SAT1 Induction in Triple-Negative Breast Cancer

被引：0
作者：
White, Chloe [1 ]
Liang, Caroline [1 ]
Velenosi, Thomas [1 ]
机构：
[1] Univ British Columbia, Vancouver, BC, Canada
来源：
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY | 2024年 / 102卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页数：37
相关论文
共 50 条
  • [21] MALT1 is activated by doxorubicin and mediates therapy resistance in triple-negative breast cancer
    Beecher, Maria
    Hu, Dong
    Klei, Linda
    Little, Jack
    McAllister-Lucas, Linda M.
    Lucas, Peter C.
    CANCER RESEARCH, 2023, 83 (07)
  • [22] Combination strategies to overcome doxorubicin induced senescence in triple-negative breast cancer
    Schreiber, Anna R.
    Smoots, Stephen
    Yacob, Betelehem W.
    Dominguez, Adrian T. A.
    Levandowski, Cecilia
    Diamond, Jennifer R.
    Pitts, Todd M.
    CANCER RESEARCH, 2022, 82 (12)
  • [23] Doxorubicin Conjugation to Reovirus Improves Oncolytic Efficacy in Triple-Negative Breast Cancer
    Berry, Jameson T. L.
    Munoz, Luis E.
    Stewart, Roxana M. Rodriguez
    Selvaraj, Periasamy
    Mainou, Bernardo A.
    MOLECULAR THERAPY-ONCOLYTICS, 2020, 18 : 556 - 572
  • [24] Enhancement of Doxorubicin Efficacy by Bacopaside II in Triple-Negative Breast Cancer Cells
    Rad, Sima Kianpour
    Yeo, Kenny K. L.
    Li, Runhao
    Wu, Fangmeinuo
    Liu, Saifei
    Nourmohammadi, Saeed
    Murphy, William M.
    Tomita, Yoko
    Price, Timothy J.
    Ingman, Wendy V.
    Townsend, Amanda R.
    Smith, Eric
    BIOMOLECULES, 2025, 15 (01)
  • [25] Characterizing the role of the nuclear coactivator AIB1 in triple-negative breast cancer.
    Cai, Shang
    Kalisky, Tomer
    Dalerba, Piero
    Clarke, Michael
    MOLECULAR CANCER RESEARCH, 2018, 16 (08) : 42 - 43
  • [26] MALSU1-mediated regulation of mitochondrial function governs proliferation and doxorubicin resistance in triple-negative breast cancer cells
    Zhuang, Feifei
    Huang, Shaoyan
    Liu, Lei
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2025, 480 (02) : 1197 - 1207
  • [27] Synergistic Effect of SH003 and Doxorubicin in Triple-negative Breast Cancer
    Woo, Sang-Mi
    Kim, Ah Jeong
    Choi, Youn Kyung
    Shin, Young Cheol
    Seong-, Sung-Gook Cho
    Ko, Seong-Gyu
    PHYTOTHERAPY RESEARCH, 2016, 30 (11) : 1817 - 1823
  • [28] Cordycepin Enhances the Therapeutic Efficacy of Doxorubicin in Treating Triple-Negative Breast Cancer
    Huang, Haichen
    Li, Xiaomin
    Wu, Wenya
    Liu, Chengyi
    Shao, Yunhe
    Wu, Xiaoping
    Fu, Junsheng
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (13)
  • [29] Characterizing the Inflammatory Profile of Neutrophil-Rich Triple-Negative Breast Cancer
    Al Qutami, Fatma
    Alhalabi, Walaa
    Vijayakumar, Aswathy
    Rawat, Surendra Singh
    Mossa, Abubakr H.
    Jayakumar, Manju Nidagodu
    Samreen, Baila
    Hachim, Mahmood Y.
    CANCERS, 2024, 16 (04)
  • [30] Triple-Negative Breast Cancer: Not Entirely Negative
    Leone, Jose Pablo
    Puhalla, Shannon
    ONCOLOGY-NEW YORK, 2013, 27 (09): : 856 - +
12345